Your browser doesn't support javascript.
loading
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation.
Rambaldi, Benedetta; Kim, Haesook T; Arihara, Yohei; Asano, Takeru; Reynolds, Carol; Manter, Mariah; Halpern, Max; Weber, Augustine; Koreth, John; Cutler, Corey; Gooptu, Mahasweta; Nikiforow, Sarah; Ho, Vincent T; Antin, Joseph H; Romee, Rizwan; Ampudia, Jeanette; Ng, Cherie; Connelly, Stephen; Soiffer, Robert J; Ritz, Jerome.
Afiliação
  • Rambaldi B; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Ph.D. Program in Translational and Molecular Medicine (DIMET), University of Milano-Bicocca, Monza.
  • Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Harvard T H Chan School of Public Health, Boston, MA.
  • Arihara Y; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Medical Oncology, Sapporo Medical University.
  • Asano T; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Hematology and Oncology, Himeji Red Cross Hospital, Hyogo.
  • Reynolds C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Manter M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Halpern M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Weber A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Cutler C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Gooptu M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Nikiforow S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Ampudia J; Equillium, La Jolla, CA.
  • Ng C; Equillium, La Jolla, CA.
  • Connelly S; Equillium, La Jolla, CA.
  • Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA. jerome_ritz@dfci.harvard.edu.
Haematologica ; 107(11): 2617-2629, 2022 11 01.
Article em En | MEDLINE | ID: mdl-35484649
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Molécula de Adesão de Leucócito Ativado Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Molécula de Adesão de Leucócito Ativado Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article